Does warfarin increase the risk of osteoporotic fracture?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 9, 2006, Pages 484-485

  Eastell, Richard ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; WARFARIN;

CONTROLLED STUDY; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HEART ATRIUM FIBRILLATION; HIP FRACTURE; HOSPITALIZATION; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT COURSE THERAPY; TREATMENT OUTCOME; VERTEBRA FRACTURE;

EID: 33748464520     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0274     Document Type: Note

References (2)

1. Szulc P et al. (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 118: 487-488
2. Caraballo PJ et al. (1999) Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos Int 9: 441-448